Stephens Consulting’s Organon & Co OGN Stock Holding History

Stephens Consulting’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5	Closed	-$87	–	501
2023 Q3	$87	Hold	5	–	–	﹤0.01%	490
2023 Q2	$105	Hold	5	–	–	﹤0.01%	488
2023 Q1	$118	Hold	5	–	–	﹤0.01%	515
2022 Q4	$140	Hold	5	–	–	﹤0.01%	490
2022 Q3	$117	Hold	5	–	–	﹤0.01%	552
2022 Q2	$169	Sell	5 -47	-90%	-$1.65K	﹤0.01%	536
2022 Q1	$1.82K	Hold	52	–	–	﹤0.01%	508
2021 Q4	$1.58K	Buy	+52	New	+$1.69K	﹤0.01%	640

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Stephens Consulting's OGN Position: Q4 2023 in Review

Stephens Consulting sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 5 shares — an estimated $87 sold.

Stephens Consulting first reported a position in OGN in Q4 2021 and held it in 8 quarters. The position peaked at $1.82K in Q1 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

Stephens Consulting reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
Stephens Consulting sold 5 Organon & Co shares in Q4 2023, an estimated $87.
Stephens Consulting first reported a position in Organon & Co in Q4 2021 and held it in 8 quarters.
Stephens Consulting's Organon & Co position peaked at $1.82K in Q1 2022.
719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Stephens Consulting's 13F filing for Q4 2023, filed 1 Feb 2024.